关注
Wells Messersmith, MD
Wells Messersmith, MD
University of Colorado
在 CUAnschutz.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Patient-derived tumour xenografts as models for oncology drug development
JJ Tentler, AC Tan, CD Weekes, A Jimeno, S Leong, TM Pitts, JJ Arcaroli, ...
Nature reviews Clinical oncology 9 (6), 338-350, 2012
13942012
Colon cancer, version 2.2021, NCCN clinical practice guidelines in oncology
AB Benson, AP Venook, MM Al-Hawary, MA Arain, YJ Chen, KK Ciombor, ...
Journal of the National Comprehensive Cancer Network 19 (3), 329-359, 2021
10532021
NCCN guidelines insights: colon cancer, version 2.2018
AB Benson, AP Venook, MM Al-Hawary, L Cederquist, YJ Chen, ...
Journal of the National Comprehensive Cancer Network 16 (4), 359-369, 2018
9032018
Rectal cancer, version 2.2018, NCCN clinical practice guidelines in oncology
AB Benson, AP Venook, MM Al-Hawary, L Cederquist, YJ Chen, ...
Journal of the National Comprehensive Cancer Network 16 (7), 874-901, 2018
8852018
Colon cancer, version 1.2017, NCCN clinical practice guidelines in oncology
AB Benson, AP Venook, L Cederquist, E Chan, YJ Chen, HS Cooper, ...
Journal of the National Comprehensive Cancer Network 15 (3), 370-398, 2017
7752017
Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial
GS Falchook, KD Lewis, JR Infante, MS Gordon, NJ Vogelzang, ...
The lancet oncology 13 (8), 782-789, 2012
6062012
Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial
JR Infante, LA Fecher, GS Falchook, S Nallapareddy, MS Gordon, ...
The lancet oncology 13 (8), 773-781, 2012
5832012
Combined BRAF and MEK Inhibition With Dabrafenib and Trametinib in BRAF V600–Mutant Colorectal Cancer
RB Corcoran, CE Atreya, GS Falchook, EL Kwak, DP Ryan, JC Bendell, ...
Journal of clinical oncology 33 (34), 4023-4031, 2015
5472015
An in vivo platform for translational drug development in pancreatic cancer
B Rubio-Viqueira, A Jimeno, G Cusatis, X Zhang, C Iacobuzio-Donahue, ...
Clinical cancer research 12 (15), 4652-4661, 2006
4952006
NCCN guidelines insights: rectal cancer, version 6.2020: featured updates to the NCCN guidelines
AB Benson, AP Venook, MM Al-Hawary, MA Arain, YJ Chen, KK Ciombor, ...
Journal of the National Comprehensive Cancer Network 18 (7), 806-815, 2020
4212020
Efficacy and safety of anti-trop-2 antibody drug conjugate sacituzumab govitecan (IMMU-132) in heavily pretreated patients with metastatic triple-negative breast cancer
A Bardia, IA Mayer, JR Diamond, RL Moroose, SJ Isakoff, AN Starodub, ...
Journal of Clinical Oncology 35 (19), 2141-2148, 2017
3842017
Rectal cancer, version 2.2022, NCCN clinical practice guidelines in oncology
AB Benson, AP Venook, MM Al-Hawary, N Azad, YJ Chen, KK Ciombor, ...
Journal of the National Comprehensive Cancer Network 20 (10), 1139-1167, 2022
3152022
Phase I study of RO4929097, a gamma secretase inhibitor of Notch signaling, in patients with refractory metastatic or locally advanced solid tumors
AW Tolcher, WA Messersmith, SM Mikulski, KP Papadopoulos, EL Kwak, ...
Journal of clinical oncology 30 (19), 2348-2353, 2012
2722012
KRAS mutations and sensitivity to epidermal growth factor receptor inhibitors in colorectal cancer: practical application of patient selection
A Jimeno, WA Messersmith, FR Hirsch, WA Franklin, SG Eckhardt
Journal of Clinical Oncology 27 (7), 1130-1136, 2009
2692009
The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma
IR Kamel, DA Bluemke, J Eng, E Liapi, W Messersmith, DK Reyes, ...
Journal of Vascular and Interventional Radiology 17 (3), 505-512, 2006
2552006
Colon cancer, version 3.2014
AB Benson, AP Venook, T Bekaii-Saab, E Chan, YJ Chen, HS Cooper, ...
Journal of the National Comprehensive Cancer Network 12 (7), 1028-1059, 2014
2472014
Rectal cancer, version 2.2015
AB Benson, AP Venook, T Bekaii-Saab, E Chan, YJ Chen, HS Cooper, ...
Journal of the National Comprehensive Cancer Network 13 (6), 719-728, 2015
2312015
A Phase I, dose-finding study in patients with advanced solid malignancies of the oral γ-secretase inhibitor PF-03084014
WA Messersmith, GI Shapiro, JM Cleary, A Jimeno, A Dasari, B Huang, ...
Clinical Cancer Research 21 (1), 60-67, 2015
2262015
Sacituzumab govitecan, a Trop-2-directed antibody-drug conjugate, for patients with epithelial cancer: final safety and efficacy results from the phase I/II IMMU-132-01 basket …
A Bardia, WA Messersmith, EA Kio, JD Berlin, L Vahdat, GA Masters, ...
Annals of Oncology 32 (6), 746-756, 2021
2052021
Pharmacogenetic pathway analysis of docetaxel elimination
SD Baker, J Verweij, GA Cusatis, RH Van Schaik, S Marsh, SJ Orwick, ...
Clinical Pharmacology & Therapeutics 85 (2), 155-163, 2009
1962009
系统目前无法执行此操作,请稍后再试。
文章 1–20